SCHWANNOMA

Clinical trials for SCHWANNOMA explained in plain language.

Never miss a new study

Get alerted when new SCHWANNOMA trials appear

Sign up with your email to follow new studies for SCHWANNOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet finished but already full! 1

Could a cancer drug shrink recurrent brain tumors?

Disease control Ongoing

This phase 2 trial is testing the drug abemaciclib in people whose primary brain tumors have come back after initial treatment. The goal is to see if the drug can shrink tumors or slow their growth. Participants take abemaciclib pills twice daily, and some take it before surgery …

Matched conditions: SCHWANNOMA

Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Jul 12, 2026 00:00 UTC

SCHWANNOMA

Get alerted when new SCHWANNOMA trials appear

Could a cancer drug shrink recurrent brain tumors?